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Cornelia deLange syndrome (CdLS) is adevelopmental disorder causedbymutations inNIPBL, a proteinwhich
has functionally been associated with the cohesin complex. Mutations in core cohesin complex components
have also been reported in individuals with CdLS-like phenotypes. In addition to its role in sister chromatid
cohesion, cohesin is thought to play a role in regulating gene expression during development. Themechanism
of thisgene regulation remainsunclear, butNIPBLandcohesinhavebeen reported toaffect long-rangechromo-
somal interactions, both independently and through interactions with CTCF. We used fluorescence in situ
hybridization to investigate whether the disruption of NIPBL affects chromosome architecture. We show that
cells from CdLS patients exhibit visible chromatin decompaction, that is most pronounced across gene-rich
regions of the genome. Cells carrying mutations predicted to have a more severe effect on NIPBL function
show more extensive chromatin decompaction than those carrying milder mutations. This cellular phenotype
was reproduced in normal cells depleted for NIPBL with siRNA, but was not seen following the knockdown of
either the cohesin component SMC3, or CTCF.We conclude that NIPBL has a function inmodulating chromatin
architecture, particularly for gene-rich areas of the chromosome, that is not dependent on SMC3/cohesin
or CTCF, raising the possibility that the aetiology of disorders associated with the mutation of core cohesin
components is distinct from that associated with the disruption of NIPBL itself in classical CdLS.
INTRODUCTION
Cornelia deLange syndrome (CdLS;OMIM122470) is a genetic
disorder characterized by characteristic facial features, abnor-
mal upper limb development, delayed growth and cognitive re-
tardation (1). These diverse clinical features are indicative of a
developmental disorder affecting the expression of multiple
genes. Interestingly, all causative mutations identified in cases
defined as CdLS have been in genes encoding proteins in the
cohesin complex or in proteins that interact with this complex.
These include NIPBL (2,3), SMC1A and SMC3 (4–7), RAD21
(8) andHDAC8 (9). The cohesin complexwas initially identified
for its role in keeping sister chromatids together during cell div-
ision until anaphase; however, recent studies have expanded the
role of this complex outside of mitosis and meiosis.
The core components of cohesin are SMC1/SMC3, Scc1/
Mcd1/Rad21 and Scc3/stromalin/SA/stag. Together these
proteins form a ring-like structure that is responsible for
holding sister chromatids together (10). While mutations in
genes encoding cohesin complex proteins have been identified
in a small subset of patients diagnosed with CdLS, up to 60%
of CdLS mutations, and 80% of mutations in the most severe
forms of the disease, involve NIPBL (nipped-B-like) which is
not a core component of cohesin (3,11–13). NIPBL (Scc2 in
Saccharomyces cerevisiae) is important for loading the
cohesin complex onto chromatin during S-phase (14). Interest-
ingly, another clinical syndrome, Roberts-SC phocomelia, has
been found to have mutations in a modulator of cohesin,
ESCO2. While sharing some similar clinical characteristics,
this syndrome has features that are distinct from CdLS (1), sug-
gesting that subtle changes in the regulation of cohesin function
can result in different phenotypes.
Individuals with CdLS are heterozygous for the mutant
NIPBL allele. Most mutant alleles are predicted to result in
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either a complete absence of protein or the production of a
severely truncated one and thus are considered to be loss of
function alleles, though missense mutations have also been
reported (3,11,13). Mouse models that are heterozygous for
mutantNipbl alleles have some of the phenotypes characteristic
of CdLS individuals, including growth retardation, craniofacial
abnormalities, heart defects and behavioural changes (15).
NIPBL mRNA expression levels in both CdLS human cells
and mouse models are 60–70% of the normal level, indicating
an up-regulation of the wild-type copy (15).
Given that the mutated proteins associated with CdLS are
known to be involved in sister chromatid cohesion, one would
expect patients to have disorders related to mitosis and
meiosis. However, CdLS cell lines do not consistently exhibit
premature sister chromatid separation (16) and the phenotypes
observed inCdLS individuals suggest a defect in gene regulation
rather than in chromatid cohesion during cell division. This may
indicate that a single functional copy of NIPBL is sufficient to
allow chromatid cohesion, but insufficient to perform interphase
functions related to developmental gene regulation. Studies of
non-dividing cells have demonstrated that components of the
cohesin complex do indeed have a role outside of cell division
(17–19).
In cell lines from CdLS human patients, as well as cells from
CdLSmouse models, a large number of genes are misexpressed
at moderate levels when NIPBL is mutated (15,20). The misex-
pressed genes aremore likely to be those that are normally bound
by cohesin, and a correlation between disease severity and the
degree of change in gene expression was found in CdLS indivi-
duals (20). Both of these results support the idea that NIPBL is
directly regulating gene expression and that it is the disruption
of this function that results in CdLS.
InDrosophilaNipped-B, the flyhomologueofNIPBL, affects
the control of transcription elongation (21) and insulator and
enhancer–promoter interactions (18,22–24). These results led
to a model in which Nipped-B and the cohesin complex can
promote long-range chromatin structures that are involved in
bringing enhancers and promoters together to regulate gene
expression.
A well-characterized protein involved in DNA looping, insu-
lation and enhancer function is the CCCTC-binding factor
(CTCF) zinc finger protein. In mammalian cells, most cohesin-
binding sites captured by chromatin immunoprecipitation
(ChIP) were first reported to be DNaseI hypersensitive sites
also boundbyCTCF (25–28).Cohesin is reported tobe involved
in long-range cis associations detected between CTCF sites at
the mammalian IFNg, APO, IgH, TCR, b-globin, HoxA and
imprinted gene loci (29–35). However, further studies have
shown thatNIPBLand cohesin can bind at promoters and enhan-
cers, alongside the Mediator complex, transcription factors and
RNA polymerase II (Rpol II), independently of CTCF (36,37).
Given the role ofNIPBL and cohesin in long-range chromatin
interactions, it is possible that cells fromCdLSpatients have dis-
rupted higher-order chromatin structure. Here, using interphase
fluorescence in situ hybridization (FISH) to assay higher-order
chromatin compaction (38), we reveal that there is a visible
decompaction of chromatin in cells derived from CdLS indivi-
duals carrying NIPBL mutant alleles. This decompaction is
widespread but is most pronounced at specific genomic
regions and in cells with the most severe mutations. Chromatin
decompaction was also observed in cells depleted of NIPBL
by siRNA. Genomic regions with a high gene density were
more likely to be decompacted in both patient cells and in
NIPBL knockdown cells than gene-poor regions. Surprisingly,
SMC3 knockdown resulted in detectable chromatin decompac-
tion at only one of the tested loci and not at the loci that were
most susceptible to NIPBL mutation or knockdown. Moreover,
the knockdown of CTCF did not result in visible chromatin
decompaction at any of the tested loci.
We conclude thatNIPBLplays an important role in chromatin
compaction, having the most impact in regions of the genome
with the highest gene density and the highest density of CTCF
and cohesin binding sites.We suggest that the effects on chroma-
tin compaction are independent of CTCF and indeed also largely
independent of SMC3. This raises the possibility that the clinical
phenotypes of CdLS individuals with NIPBL mutation might
result from the perturbation of a function of NIPBL that is
independent of its role in cohesion or cohesin biology.
RESULTS
Nuclear size in CdLS cell lines
To determine whether there are global changes in chromatin
compaction associated with the mutation of NIPBL, we first
analysed nuclear size in fixed lymphoblastoid cell lines (LCLs)
from individuals with a severe CdLS phenotype. Many factors
affect nuclear size within a particular cell type, but chromatin
decompaction is known to result in nuclear swelling (39–41).
Cell lines were chosen that carry different types of mutations
in NIPBL with predicted differing effects on the resulting
protein. CdL223P carries an NIPBL allele with a deletion of
exons 2–17 that removes the start codon for NIPBL (Fig. 1A
and Table 1) (42). CdL125P carries an allele with a very early
frameshift (11) that is the most common mutation found in
CdLS (43) and is expected to create no, or a severely truncated,
Table 1. CdLS cell lines
Cell line Mutation type Location of mutation in NIPBL Amino acid change in NIPBL Karyotype Reference
CdL 223 P Microdeletion Deletion of exons 2–17 No start codon 46XX (42)
CdL 125 P Frameshift 2479_2480delAG R827GfsX2 50% 46XX, 50% 44XX + fusion (poss 1;16) (11,43)
AG0088 Frameshift 7306_7307 ins G S2435X 46XY (2)
AG0805 Splice site 5575–2 A. G No exon 30 46XX (2)
The type ofmutation inNIPBL in the fourCdLSLCLcell lines studied is indicated as is the predicted effect onNIPBLprotein. Patient phenotypeswere reported in the
indicated references. Karyotypes for three of the four cell lines were normal. For CdL125P cell line, 50% of metaphases were normal 46XX but in 50% of cells there
was a fusion chromosome. This did not appear to involve any of the regions analysed in this paper.
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Figure 1.Characterization ofNIPBLcell lines. (A) Representation ofNIPBLproteinwith themain protein domains shownbelow and the location ofCdLSmutations
in LCLs indicated above. Orange represents a microdeletion, red a frameshift, blue a splice site mutation and green a nonsense mutation. (B) Box plots showing the
distribution of nuclear sizes (mm2) in fixed nuclei from control and CdLS LCLs. Data from CdLS lines CdL223P and CdL125 are shown on the left together with a
wild-typeunaffected sibling (WT).AGO805andAG0088are shownon the right togetherwith an independentWTcontrol (575).Horizontal lines show themeans and
the boxed area is the interquartile range (IQR). Whiskers show 1.5 IQR of the upper and lower quartile. n. 100 loci each, P , 0.001. (C) Sample images of
DAPI-stained nuclei from wild-type and patient cells demonstrating differences in nuclear size. Scale bar ¼ 10 mm. (D) Fluorescence-activated cell sorting
(FACS) analysis of DNA content from PI stained WT (575), AG0805 and AG0088 cells.
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protein. Two other cell lines have point mutations within
(AG0805), or just after (AG0088), the conserved C-terminal
HEAT domains (2), which have been shown to be necessary to
recruit NIPBL to sites of DNAdamage (44) as well as mediating
protein–protein interactions (45,46). By imaging 4′,6-diami-
dino-2-phenylindole (DAPI) stained fixed nuclei, we found
that CdLS cell lines had a significant increase in nuclear size dis-
tribution relative towild-type LCLs (P, 0.001; Fig. 1B andC).
Nuclear size increases during the cell cycle, so one possibility
was that CdLS cell lines have an altered cell cycle profile,
perhaps resulting from aberrant sister chromatid cohesion.
However, fluorescence-activated cell sorting (FACS) analysis
showed that theCdLSLCLshave anormal cell cycle distribution
relative to control LCLs (Fig. 1D). Therefore, we conclude that
the increased nuclear size we observe in CdLS cells is not the
result of abnormal cell cycle dynamics and may instead reflect
altered chromatin compaction.
Regional chromatin decompaction in CdLS cell lines
correlates with NIPBL mutation
TodeterminewhetherNIPBLmutations affect higher-order chro-
matincompactionatparticular loci,weselectedspecific regionsof
the human genome to examine in more detail. The five regions
were chosen to represent a variety of different genomic character-
istics (Table 2).Because of the reported binding ofNIPBLat gene
promoters in association with Rpol II and Mediator (36), we
selected two regions of low gene and CpG island (CGI) density,
11p12 and 18q22.2 (Fig. 2A and B), one of moderate gene
density, 18p11.3 (Fig. 2C), and two regions, 11q13.3 and
19q13.3, of highgeneandCGIdensity (Fig. 2DandE).Moreover,
11q13.3 is also a region of the human genome (RIDGEs) where
densely packed genes are also expressed to a high level (47).
Rpol II binding was also ascertained from the ChIP data for
LCLs established by ENCODE (48). No Rpol II binding is
detected at either of the low gene-density regions, while peaks
of binding are found scattered throughout the other three
regions. In agreement with this, gene expression data from
human LCLs show transcripts originating from the high and
moderate gene-density regions, while no transcripts are detected
in the regions of low gene density (49).
The selected regions also have different CTCF binding pro-
files that largely follow the trends in gene density consistent
with the location of many CTCF sites close to the transcription
start sites of genes (50,51). Finally, and as expected given the
correlation between CTCF and cohesin subunit ChIP signals
(25–28), cohesin density (SMC3 ChIP peaks) also varies
across the selected genomic regions in line with gene density
(Fig. 2 and Table 2).
We assayed higher-order chromatin compaction in control
and CdLS LCLs at these five selected genomic regions by
FISH using probe pairs separated by 250 kb (Fig. 2 and
Table 2). The mean-squared interprobe distance (d2) between
hybridization signals for such probe pairs is known to have a
linear relationship with genomic separation (kb) over this size
range and can be used tomeasure changes in chromatin compac-
tion both between different regions of the same genome (52,53)
and between different cell types—e.g. during differentiation and
development (54,55).Moreover, suchanalysis candetermine the
role of specific histone modifications and proteins in chromatin
compaction in wild-type andmutant cells (38). In order to detect
effects that are locus-specific as opposed to those that are just a
reflection of genome-wide chromatin decompaction and
increased nuclear size, data were normalized to the nuclear
radius (r2), as described previously (38).
FISH analysis at regions of low to moderate gene density
(Fig. 3) showed that in three of the four CdLS cell lines, there
was no significant change (P . 0.05, Table 3) in regional chro-
matin compaction compared with wild-type cells. There was
also no altered chromatin compaction detected at the 18q22
locus inCdLS linesAG0805 andAG0088with a probepair sepa-
rated by a larger (400 kb) genomic distance (data not shown).
The only cell line where there was a significant decrease in re-
gional chromatin compaction (increase in d2/r2) in regions of
low gene density, relative to control cells, was CdL223P, the
cell line that is expected to have the most profound impairment
of NIPBL function.
In contrast, at the two regions of high gene and high CTCF/
SMC3 density, significant chromatin decompaction was seen
across the 250 kb size range in both CdL223P and CdL125P
cell lines (Fig. 4A, B and D). Moreover, for CdL223P cells,
the extent of decompaction measured at these loci relative to
Table 2. Characteristics of Fosmid probe locations
Chromosome Whitehead
probe name
Other probename Start (bp) End Midpoint Separation
between probe pair
midpoints (bp)
Genes/
100 kb
CGI/
100 kb
CTCF/
100 kb
SMC3/
100 kb
11p12 WI2-1843D17 G248P86589B9 40 702 638 40 738 514 40 720 576 256 605.0 ,1 0 0 0
WI2-0676N14 G248P80235G7 40 441 561 40 486 381 40 463 971
18q22.2 WI2-1702P7 G248P87869H4 64 134 988 64 175 629 64 155 309 238 833.5 0 0 1.6 1
WI2-502C21 G248P8988B11 63 893 119 63 939 831 63 916 475
18p11.3 WI2-0672M24 G248P80018G12 3 467 167 3 506 775 3 486 971 250 195.0 3 1.5 5.5 3.5
WI2-1795M06 G248P86030G3 3 217 757 3 255 795 3 236 776
11q13.3 WI2-671I21 G248P80020E11 64 768 160 64 811 897 64 790 029 249 082.0 9 9 9 10
WI2-1737E8 G248P86034C4 65 019 283 65 058 937 65 039 110
19q13.3 WI2-1832N17 G248P86553G9 46 105 895 46 147 486 46 126 691 241 287.0 7 7 12 13
WI2-1336P19 G248P84001H10 45 865 675 45 905 133 45 885 404
Probe names are from the Whitehead Fosmid database (http://bacpac.chori.org/library.php?Id=275). Alternative probe names can be used to view fosmids on the
UCSC genome browser. All genome locations are reported as hg19 coordinates. Gene, CGI, CTCF and SMC3 peak densities are estimates based on UCSC genome
browser and Encode datasets and averaged for a 100 kb region.
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Figure 2. Genomic regions used for FISH analyses. UCSC genome browser images showing the location of FISH probes in the five tested genomic regions. Map
position (Mb) and RefSeq gene annotations are from the February 2009 (hg19) assembly of the human genome (http://genome.ucsc.edu). Positions of UCSC
genes and CGIs are also indicated. ChIP peaks for CTCF, Rpol II and SMC3 are from ENCODE data for GM12878 LCLs. (A) Chromosome 11p12 region with
low gene density. (B) Chromosome 18q22.2 region with low gene density. (C) Chromosome 18p11.3 region with moderate gene density. (D) Chromosome
11q13.3 region with high gene density. (E) Chromosome 19q13.3 region with high gene density.
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wild-type cellswas greater (2.4-fold for 11q13.3 and 3.7-fold for
19q13.3) than that at the regions ofmoderate to low gene density
(,2-fold; Table 3). The 11q13.3 region was also analysed in
AG0805 and AG0088 CdLS cell lines (Fig. 4A). Significant
chromatin decompaction was seen in AG0805, but not in
AG0088 which potentially has the mildest mutation, a nonsense
mutation at the extremeC-terminus ofNIPBL (Fig. 1A). Signifi-
cant chromatin decompaction was, however, seen in AG0088
cells when the probe pair separation was increased to 500 kb
(Fig. 4C).
To exclude that the increased nuclear distances seen by FISH
in CdLS patients could be due to a genomic alteration, e.g. copy
number variation, in the regions being tested, we used array
comparative genome hybridization (array CGH) on genomic
DNAs prepared from AG0805, AG0088 and CdL125P. The
results showed no indication of gross genomic rearrangements
at a genome-wide level in any of the three samples analysed.
Detailed inspection of the regions examined by FISH revealed
no significant changes in genomic copy number in those
regions (Supplementary Material, Fig. S1).
Fromourdata,weconclude that lossofNIPBLfunctioncausesa
large-scale unfolding of higher-order chromatin structure that can
be detected by FISH and that this occurs to the greatest extent
in genomic regions with the highest gene density and the
highest density of CTCF and cohesin binding sites. Our data
also suggest that different mutations of NIPBL impact on the
extent of chromatin decompaction, with the most severe cellular
phenotype seen in the cases where the mutation is predicted to
have themostsevereeffectonNIPBLproteinandprotein function.
Chromatin decompaction after knockdown of NIPBL
Because NIPBL expression levels are reported to be reduced to
only 60–70% of wild-type levels in CdLS (15,20), we analysed
the effects on chromatin compaction of more severely reduced
levels of NIPBL, achieved by siRNA knockdown in HT1080
human fibrosarcoma cells. Knockdown of NIPBL at both the
mRNA and the protein level was confirmed by quantitative
reverse transcription PCR (rtPCR) and western blot (Fig. 5A
Figure 3. Chromatin compaction at gene-poor regions in CdLS. Box plots show the distribution of interprobe distances2 (d2) normalized for nuclear radius2 (r2) in
FISHacross 250 kb regions in unaffected andCdLSpatient cell lines. The shadedboxes show themedian and interquartile range of the data; asterisks indicate outliers.
Thestatistical significanceofdifferences betweenunaffectedsiblingand theCdLScell linesweredeterminedby theMann–WhitneyU-tests.AllP-valuesare reported
in relation to unaffected cells in Table 3 and significant values are indicated below the graphs. (A) 11p12 gene and CTCF low region, n . 95. (B) 18q22.2 gene and
CTCF low region, n . 97. (C) 18p11.3 regionwithmoderate gene andCTCF density, n . 87. (D) Example FISH images fromWT, CdL223P andCdL125P cells for
the 11p12 region. Bar represents 5 mm.
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and B). We estimate that NIPBL protein and mRNA levels are
reduced to 20% of those in untreated cells (Fig. 5A and C).
FISH was then performed on these cells to assess the conse-
quence of NIPBL knockdown on chromatin compaction at the
same five specific genomic regions that had been examined in
CdLS cells. At the gene/CTCF/cohesin poor region on chromo-
some 11 (Fig. 2A), there was no detectable change in relative
chromatin compaction in NIPBL knockdown cells compared
with either untransfected cells or a random siRNA control
(Fig. 6A and Table 4).
However, at all other loci tested, significant chromatindecom-
paction was seen after NIPBL knockdown compared with either
the untreated cells or the random siRNA control (Fig. 6B–E and
Table 4). As in CdLS cells, the extent of chromatin decompac-
tion after NIPBL knockdown was greater at the gene-dense
regions than at gene poor loci.
Absence of chromatin decompaction after the knockdown
of CTCF and SMC3
NIPBL could exert its effect on chromatin compaction through
its role in cohesin loading. This would be consistent with the
fact that some cases diagnosed as CdLS are associated with
mutations in the cohesin complex itself. In order to evaluate
the role of other components of the cohesin complex in chroma-
tin compaction, we knocked down SMC3 in the HT1080 cells.
Knockdown was confirmed by rtPCR and western blot
(Fig. 5D–F). Expression of SMC3 was reduced to 55% the
level in untreated cells after specific siRNA treatment.
FISH on SMC3 knockdown cells did not reveal the same ex-
tensive chromatin decompaction across the tested genomic
regions as was seen with NIPBL knockdown (Fig. 6 and
Table 4). This is particularly significant since SMC3knockdown
did appear to reduce NIPBL protein levels to a small degree
(Fig. 5C). Therewas a small effect (,2-fold) on chromatin com-
paction at 18q22.2 after SMC3knockdown, although paradoxic-
ally there are no annotated SMC3/cohesin binding sites at this
genomic region (Fig. 2B), but there was no chromatin decom-
paction detected at the gene-dense regions with the highest
density of SMC3 ChIP peaks and which are the regions also
most affected by NIPBL knockdown (Fig. 2D and E). This sug-
gests that the effects ofNIPBLon chromatin compactionmay be
independent of the cohesin complex itself.
Since many NIPBL sites have been reported to be coincident
with CTCF binding sites (25–28) and CTCF has been suggested
to affect higher-order chromatin conformation through chroma-
tin compaction (32) and ‘looping’ (56,57), we also assayed
higher-order chromatin compaction after CTCF knockdown by
siRNA. CTCF RNA and protein levels were reduced to 60%
of wild-type (Fig. 5G–I).
Theonly significant change inchromatin compactiondetected
by FISH after CTCF knockdown was at the 11q13 locus, and in
fact this was a decrease in d2/r2 and d2 values comparedwith un-
treated cells (Table 4), i.e. an increase in chromatin compaction.
Although NIPBL knockdown appears to significantly reduce
levels of CTCF as well as NIPBL (Fig. 5I), given the absence
of detectable chromatin decompaction upon CTCF knockdown,
we conclude that the decompaction of chromatin seen in NIPBL
depleted or NIPBL mutant cells is attributable to NIPBL itself
and is not due to the association of NIPBL with a cohesin
component (SMC3) or with CTCF.
DISCUSSION
The most common gene mutated in individuals diagnosed as
CdLS is NIPBL. However, the link between the genotype of
Table 3. Statistical results from FISH analysis of CdLS cell lines
11p12 18q22.2 18p11.3 11q1.3 19q13.3
Normalized interprobe distance (d2/r2)
Unaffected sibling 0.00162 0.00161 0.00206 0.00295 0.00206
CdL223P 0.00324 0.0022 0.00365 0.00713 0.00758
P ¼ 0.0054 P ¼ 0.0388 P ¼ 0.0031 P ¼ 0.0006 P , 0.0001
CdL125P 0.00155 0.00122 0.00278 0.00552 0.00575
P ¼ 0.8593 P ¼ 0.0822 P ¼ 0.1022 P ¼ 0.0085 P , 0.0001
WT (575) 0.002 0.0036
AG0805 0.0013 0.0043
P ¼ 0.688 P ¼ 0.007
AG0088 0.002 0.0035
P ¼ 0.787 P ¼ 0.178
Squared interprobe distance (d2)
Unaffected sibling 0.1698 0.1782 0.1991 0.3305 0.1991
CdLS 223P 0.3548 0.1726 0.4181 0.7442 0.7598
P ¼ 0.0014 P ¼ 0.7038 P ¼ 0.0001 P ¼ 0.0016 P , 0.0001
CdLS patient 125 0.2003 0.1251 0.3429 0.8425 0.8723
P ¼ 0.4797 P ¼ 0.1336 P ¼ 0.0035 P , 0.0001 P , 0.0001
WT (575) 0.15 0.41
AG0805 0.25 1.04
P ¼ 0.118 P ¼ 0.001
AG0088 0.16 0.49
P ¼ 0.495 P ¼ 0.697
Meannormalizeddistance (d2/r2) and squared interprobedistances (d2) forFISHdata fromcontrol andCdLSLCLsatfivegenomic loci, usingprobepairs separatedby
250 kb.P-valueswere generated using theMann–WhitneyU non-parametric test comparing CdLS towild-type controls. SignificantP-values (,0.05) are indicated
by shaded boxes.
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these individuals and their biological phenotypes remains
unclear. It is accepted that the CdLS clinical phenotypes asso-
ciated with NIPBL mutation are not the result of mitotic/
sister chromatid cohesion defects, but instead result from the
altered regulation of gene expression. This is consistent with
the reported genomic localization of NIPBL with components
of the transcriptional machinery (36). How perturbation of
NIPBL affects gene expression has not been established.
Here, we have demonstrated that there is a decompaction of
higher-order chromatin structure at a subset of genomic
regions in cells from CdLS individuals and that this is seen
to the greatest degree at regions that are gene-rich and
characterized by a high density of binding sites for cohesin
and CTCF as assessed by ChIP (Figs 3 and 4). We provide evi-
dence that the extent to which chromatin compaction is per-
turbed is linked to the likely severity of the NIPBL mutation,
and this is further supported by the extensive chromatin
decompaction we report after NIPBL knockdown by siRNA
(Figs 5 and 6). These observations are consistent with the
chromatin decondensation seen in budding yeast with
mutations analogous to CdLS mutations, in Scc2—the yeast
homologue of NIPBL (58).
Given that bothNIPBLandcohesinaffect long-range chroma-
tin interactions in genetic assays, and cohesin affects chromatin
conformation asmeasured in3Ccross-linking assays (29,30,32),
we evaluated chromatin compaction in cells after the knock-
down of the cohesin component SMC3. This did not phenocopy
the effect seen either with NIPBL knockdown or in
CdLS-associated NIPBL mutant cells.
Despite the fact thatmanyNIPBL sites appear coincidentwith
CTCF binding sites (25–28) and CTCF has been suggested to
affect higher-order chromatin conformation (32,56,57), we
also did not see chromatin decompaction after CTCF knock-
down, even at genomic regions with the highest density of
CTCF binding sites. We note that we were unable to decrease
the levels of CTCF below 60% by siRNA treatment—CTCF is
required for cell viability and division and is notoriously hard
to knockdown (59). However, we did paradoxically observe an
increase in chromatin compaction at the 11q13.3 locus after
CTCF knockdown, indicating that knockdown was significant
Figure 4.Chromatin compaction at gene-rich regions in CdLS. As in Figure 3 but for (A) 11q13.3 gene- and CTCF-rich region, n. 100 and (B) 19q13.3 gene- and
CTCF-richregion,n. 95.AllP-valuesare reported in relation tounaffectedsibling inTable3andsignificantvaluesare indicatedbelowthegraphs. (C) 11q13.3gene-
andCTCF-rich region, assayedwith probes separated by 400 kb, n . 100. (D) Example FISH images fromWT,CdL223P andCdL125P cells for 19q13.3. Bar repre-
sents 5 mm.
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Figure 5.Knockdown of NIPBL, SMC3 and CTCF. (A) Real-time quantification of NIPBLmRNA levels relative to those for the mRNA of NADH dehydrogenase
(ubiquinone) 1 alpha (NDUFA1) in untreated cells, in mock transfected cells and in cells transfected with random siRNAs or with NIPBL-specific siRNA. All values
are normalized to levels in untreated cells (value of 1). All analysis performed in triplicate. (B) Western blot for NIPBL and actin in untreated cells and in cells after
siRNAknockdownforCTCF,NIPBLandSMC3.Data for transfectionwith a randomsiRNAcontrol are also shown. (C)QuantificationofNIPBLprotein levels based
onwestern results. Samples normalizedwith actin levels and relative to the ratio in untreated cells. (D)As in (A) but for SMC3 knockdown. (E)As in (B) but for SMC3
and PCNA. (F) As in C but SMC3 protein levels normalized to those of PCNA. (G,H and I) As in (D), (E) and (F) but for CTCF knockdown.
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Figure 6. Regional chromatin compaction after NIPBL, SMC3 and CTCF knockdown. Box plots show the distribution of interprobe distances2 (d2) normalized for
nuclear radius2 (r2) in untreated cells and after knockdownwith siRNAs againstNIPBL, SMC3,CTCF andwith randomsiRNAs.AllP-values are reported in relation
to untreated cells (Table 4) and are indicated here by ∗P , 0.05 and.0.01, ∗∗P , 0.01 and.0.001 and ∗∗∗P , 0.001 and.0.0001.Analysis at (A) 11p12 gene- and
CTCF-poor region, n . 105; (B) 18q22.2 gene- and CTCF-poor region, n . 100; (C) 18p11.3 region with moderate gene and CTCF density, n . 110; (D) 11q13.3
gene- and CTCF-rich region, n. 100; (E) 19q13.3 gene- and CTCF-rich region, n . 100.
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enough tohave an impact on chromatin structure, albeit not in the
expected direction.
Our data, therefore, suggest thatNIPBLcan affect higher-order
chromatin folding, independent of cohesin andCTCF. This raises
the possibility that the underlying aetiology of disorders asso-
ciated with the mutation of core cohesin components is different
from that associated with the disruption of NIPBL. Individuals
identified with mutations of SMC1A and SMC3 have relatively
mild phenotypes, often with atypical facial features and fewer
limb and digit abnormalities than those which characterize
classicCdLSwithNIPBLmutation(6,13,43).Thishasbeenattrib-
uted to the fact that theSMC1A/SMC3mutationshaveapredicted
modest affect on protein structure—more severe mutations are
assumed to be incompatible with birth—but it could also reflect
a fundamental difference in the cellular functions of NIPBL and
cohesin and a different aetiology for NIPBL-associated CdLS
and the CdLS-like diseases associated with mutations in cohesin
components. This would be consistent with the differences in
dysregulated gene expression seen in zebrafish morphants for
nipbl and those depleted in cohesin components (60).
Future work to dissect the regional differences in susceptibil-
ity to chromatin decompaction associatedwithNIPBLmutation,
to establish how this level of chromatin structure is linked to the
disruptionof geneexpression and toexamine this indifferent cell
types and at different developmental stages in animal models of
CdLS has the potential to provide new insight into the mechan-
isms of CdLS-like diseases.
MATERIALS ANDMETHODS
Cell culture
LCLs were cultured in RPMI-1640 supplemented with 0.2 mM
L-glutamine, 100 U/ml penicillin, 100 mg/ml streptomycin and
20% fetal calf serum (FCS). HT1080 fibrosarcomma cells (61)
were cultured in Dulbecco’s modified Eagle medium (Invitro-
gen) supplemented with 0.2 mM L-glutamine, 100 U/ml penicil-
lin, 100 mg/ml streptomycin and 10% FCS. For cell cycle
analysis, harvested cells were resuspended in 50% FCS/
phosphate buffered saline (PBS), 3× volume 70% ice-cold
ethanol was added and cells were stored at 48C. Cells were
Table 4. Statistical results for FISH analysis of siRNA knockdown of NIPBL, SMC3 and CTCF
Mean normalized distance (d2/r2) and squared interprobe distances (d2) for FISHdata fromuntreatedHT1080 cells and fromcells transfectedwith randomsiRNAsor
siRNAs specific for NIPBL, SMC3 or CTCF. FISH was conducted at five genomic loci, using probe pairs separated by 250 kb. P-values were generated using the
Mann–Whitney U non-parametric test comparing specific siRNA knockdown to untreated (first value) or to random siRNA (second value). Significant P-values
(,0.05) are indicated by shaded boxes. If P-values are significant for only comparison to untreated, or control siRNA, but not both, then boxes are stippled.
Table 5. Sequences of On-Targetplus SMARTpool siRNA
SMC3 gcagugcaacacagaauua gagaguagaugcacugaau gguguaaaguucagaaaua caacguagcuuacagaguu
CTCF gaacagcccauaaacauag gaagaugccugccacuuac ggagaaacgaagaagagua gaugaagacugaaguaaug
NIPBL gggcuuguuucaauagaua acacuucacuucuaacaaa caacagaucacauagaguu gauauaaaccgcccacuaa
Table 6. Primers for real-time rtPCR
Primer name Primer sequence Product size
CTCFrealF TGACACAGTCATAGCCCGAAAA 74
CTCFrealR TGCCTTGCTCAATATAGGAATGC
NIPBL2F GGAGTGACATGGCTAATTCC 103
NIPBL2R TCATCAGGGTCCAGATGTTC
SMC3F TTGACCAGGCTCTGGATG 250
SMC3R CTCCCAAACCAGTAGGTAG
NDUFA1F ACTGGCTACTGCGTACATCC 104
NDUFA1R AGATGCGCCTATCTCTTTCC
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then washed with PBS and resuspended in propidium iodide so-
lution (50 mg/ml PI + 100 mg/ml RNAse) for 1 h prior to FACS
analysis on a BD FACSAria2 SORP. Cells were excited at
488 nm and measured at 562–588 nm. Data were analysed
using BD FACSDiva Software version 6.1.3.
FISH, image capture and analysis
Nuclei were isolated in hypotonic buffer (0.25%KCl) and fixed
with 3:1 v/vmethanol/acetic acid. Fosmid clones (Table 2) were
prepared and labelled with digoxigenin-11-dUTP or with
biotin-16-dUTP as described previously (55). After hybridiza-
tion, digoxigenin-labelled probes were detected using Rhoda-
mine anti-digoxigenin and Texas Red anti-sheep IgG (Vector
Laboratories). Biotin-labelled probes were detected using
fluorescein–streptavidin and biotinylated anti-avidin (Vector
Laboratories).
Slides were analysed as described previously (55) except that
aChroma#83000 triple band pass filter set (ChromaTechnology
Corporation, Rockingham, VT, USA) and a motorized filter
wheel (Prior Scientific Instruments, Cambridge, UK)were used.
Array CGH
Genomic DNAwas prepared from LCLs using a Nucleon DNA
extraction kit (Tepnel Life Sciences, UK). DNA was quantified
by NanoDrop spectrophotometry (Thermo Scientific).
Genome-wide analysis of DNA copy number aberrations was
carried out using the Roche Nimblegen 135k whole-genome
array (median probe spacing of12 kb) according to the manu-
facturer’s instructions, as described previously (62). After
washing, slides were scanned using the Roche MS200 scanner
and analysed using NimbleScan software (Roche Nimblegen).
The CGH-segMNT module of NimbleScan was used for the
analysiswith aminimumsegment lengthof 5probes and anaver-
agingwindow of 130 kb. The results were analysed by obtaining
the log2 ratios of the case (labelledwithCy-5) comparedwith the
control (labelled with Cy-3). A heterozygous deletion and a
heterozygous duplication are expected to result in log2 ratios
of 21.0 and 0.58, respectively. Similarly, a homozygous dele-
tion and a homozygous duplication are expected to result in
log2 ratios of 22.0 and 1.0, respectively. Genomic coordinates
were converted from hg19 to hg18 for analysis, using the
UCSC Lift Genome Annotations utility.
SiRNA knockdown
SiRNA-mediated knockdown was performed using On-
Targetplus SMARTpool siRNA mixes (Thermo Scientific),
designed with dual-strand modification that decreases off target
effects and containing a mix of four individual siRNAs
Table 5).The randomerwas theON-TARGETplusNon-targeting
Control Pool. siRNAswere diluted as directed by themanufactur-
er to a stock concentration of 100 mM in the supplied 1× siRNA
buffer.A10 cmdishofHT1080cells at 90%confluencewas lipo-
fected with 165 pmol siRNAs using Lipofectamine 2000. Cells
were harvested for RNA and protein 50 h post-transfection.
Real-time PCR
RNAwas isolated using Qiagen RNA Easy Kit. 500 ng of RNA
were reverse transcribed in a 20 ml reaction using Superscript II.
1 ml of cDNA was amplified using specific primers (Table 6)
and SYBER green real-time master mix (Life Technologies).
Real-time analysis was performed using a Roche LightCycler
480. The programme for amplification was 958C × 3 min,
then 45 cycles of 958C × 15 s, 62oC × 15 s and 72oC × 30 s.
The melting curve programme was 958C × 5 s and 658C ×
1 min, and then readingswere acquiredwhile increasing the tem-
perature by 0.118C/s to 978C.
Immunoblotting
Protein was isolated from a 6-well plate of cells. 100 ml of
4× SDSLB (2.0 ml 1 M Tris–HCl, pH 6.8, 0.8 g sodium
dodecyl sulphate SDS), 4.0 ml of 100% glycerol, 0.4 ml of
14.7 M b-mercaptoethanol, 1.0 ml of 0.5 M ethylenediaminete-
traacetic acid 8 mg bromophenol blue) and 300 ml PBS were
added to the cells. The cells and liquid were collected from the
wells, boiled for 5 min and then sonicated for 20 s (Bioruptor
NextGen Diagenode) prior to loading directly onto gels. For
analysis of NIPBL, samples were run on a NuPage TrisAcetate
3–8% gel (Life Technologies) using the NuPage running
buffer. For CTCF and SMC3, samples were run on a standard
10%SDS polyacrylamide gel. Gels were transferred onto polyvi-
nylidene fluoride membranes by semidry transfer at 10 V for 1 h.
The membrane was blocked for 1 h in 5% milk PBST (0.1%
Tween-20 in Dulbecco A PBS; Oxoid). NIPBL was detected
with the anti-IND3 rat monoclonal antibody (AbCAM
#131913) diluted 1:500. For Smc3, anti-SMC3 rabbit polyclonal
antibody (Bethyl A300-060A) was used at a 1:1000 dilution. For
CTCF, anti-CTCF rabbit polyclonal antibody (Upstate 07-729)
was used at a 1:2000 dilution. Membranes were incubated with
antibodies overnight in 1.5% milk PBST at 48C, washed 3×
with PBST and incubated with the appropriate horseradish
peroxidase-conjugated secondary antibody at a 1:10 000 dilution
at room temperature for 1 h. Signal was detected by ChemiGlow
West (Alpha Innotech) and imaged using Image Quant LAS4010
(Version 1, Build 1.0.0.52; GE Healthcare).
SUPPLEMENTARYMATERIAL
Supplementary Material is available at HMG online.
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